HSBC Holdings
BNGO icon

HSBC Holdings’s Bionano Genomics BNGO Stock Holding History

HSBC Holdings’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-29
Closed -$24K – 2942
2022
Q2 		$24K Sell
29
-11
-28% -$11.3K ﹤0.01% 3186
2022
Q1 		$63K Buy
40
+2
+5% +$2.7K ﹤0.01% 3181
2021
Q4 		$70K Buy
38
+17
+81% +$45.5K ﹤0.01% 3178
2021
Q3 		$69K Sell
21
-6
-22% -$21K ﹤0.01% 2916
2021
Q2 		$119K Buy
+27
New +$107K ﹤0.01% 2833

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

HSBC Holdings's BNGO Position: Q3 2022 in Review

HSBC Holdings sold out of Bionano Genomics (BNGO) in Q3 2022, closing a stake of 29 shares — an estimated $24K sold.

HSBC Holdings first reported a position in BNGO in Q2 2021 and held it in 5 quarters. The position peaked at $119K in Q2 2021. 140 funds tracked by Wall St. Rank hold BNGO as of Q3 2022.

  • HSBC Holdings reported no remaining Bionano Genomics position as of Q3 2022 after selling out during the quarter.
  • HSBC Holdings sold 29 Bionano Genomics shares in Q3 2022, an estimated $24K.
  • HSBC Holdings first reported a position in Bionano Genomics in Q2 2021 and held it in 5 quarters.
  • HSBC Holdings's Bionano Genomics position peaked at $119K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.